The inhibitory effect of matrix metalloproteinase inhibitor ONO-4817 on lymph node metastasis in tongue carcinoma

Taku Yamashita, Masato Fujii, Toshiki Tomita, Ryuichiro Ishiguro, Masatsugu Tashiro, Yutaka Tokumaru, Yorihisa Imanishi, Minoru Kanke, Kaoru Ogawa, Kaori Kameyama, Yoshihide Otani

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Background: ONO-4817 is a novel matrix metalloproteinase (MMP) inhibitor which has a broad inhibitory spectrum for MMPs. We investigated the inhibitory effect of ONO-4817 on cervical lymph node metastasis of tongue carcinoma. Materials and Methods: HSC-3-M3, a cell line derived from human tongue carcinoma with high metastatic potential for lymph node, was used. The direct cytotoxicity of ONO-4817 was assessed by MTT assay and the gelatinolytic activity by gelatin zymography and film in situ zymography (FIZ). The inhibitory effect on lymph node metastasis was examined by orthotopic implantation model with nude mice. Results: ONO-4817 had no direct cyototoxicity on HSC-3-M3 cells. Gelatin zymography and FIZ demonstrated a suppression of MMP-9 activation and a marked inhibition of gelatinolysis. Additionally, a suppression of cervical lymph node metastasis was shown by therapeutic experiment. Conclusion: The MMP inhibitor, ONO-4817, is a candidate for adjunctive therapy of cervical lymph node metastasis in tongue carcinoma.

Original languageEnglish
Pages (from-to)2297-2302
Number of pages6
JournalAnticancer Research
Volume23
Issue number3 B
Publication statusPublished - 2003 May

Fingerprint

Matrix Metalloproteinase Inhibitors
Tongue
Lymph Nodes
Neoplasm Metastasis
Carcinoma
Matrix Metalloproteinase 9
Matrix Metalloproteinases
Nude Mice
N-hydroxy-5-ethoxymethyloxy-2-methyl-4-(4-phenoxybenzoyl)aminopentanamide
Cell Line
Therapeutics

Keywords

  • Head and neck squamous cell carcinoma
  • Lymph node metastasis
  • Matrix metalloproteinase inhibitor
  • ONO-4817
  • Orthotopic implantation model

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Yamashita, T., Fujii, M., Tomita, T., Ishiguro, R., Tashiro, M., Tokumaru, Y., ... Otani, Y. (2003). The inhibitory effect of matrix metalloproteinase inhibitor ONO-4817 on lymph node metastasis in tongue carcinoma. Anticancer Research, 23(3 B), 2297-2302.

The inhibitory effect of matrix metalloproteinase inhibitor ONO-4817 on lymph node metastasis in tongue carcinoma. / Yamashita, Taku; Fujii, Masato; Tomita, Toshiki; Ishiguro, Ryuichiro; Tashiro, Masatsugu; Tokumaru, Yutaka; Imanishi, Yorihisa; Kanke, Minoru; Ogawa, Kaoru; Kameyama, Kaori; Otani, Yoshihide.

In: Anticancer Research, Vol. 23, No. 3 B, 05.2003, p. 2297-2302.

Research output: Contribution to journalArticle

Yamashita, T, Fujii, M, Tomita, T, Ishiguro, R, Tashiro, M, Tokumaru, Y, Imanishi, Y, Kanke, M, Ogawa, K, Kameyama, K & Otani, Y 2003, 'The inhibitory effect of matrix metalloproteinase inhibitor ONO-4817 on lymph node metastasis in tongue carcinoma', Anticancer Research, vol. 23, no. 3 B, pp. 2297-2302.
Yamashita T, Fujii M, Tomita T, Ishiguro R, Tashiro M, Tokumaru Y et al. The inhibitory effect of matrix metalloproteinase inhibitor ONO-4817 on lymph node metastasis in tongue carcinoma. Anticancer Research. 2003 May;23(3 B):2297-2302.
Yamashita, Taku ; Fujii, Masato ; Tomita, Toshiki ; Ishiguro, Ryuichiro ; Tashiro, Masatsugu ; Tokumaru, Yutaka ; Imanishi, Yorihisa ; Kanke, Minoru ; Ogawa, Kaoru ; Kameyama, Kaori ; Otani, Yoshihide. / The inhibitory effect of matrix metalloproteinase inhibitor ONO-4817 on lymph node metastasis in tongue carcinoma. In: Anticancer Research. 2003 ; Vol. 23, No. 3 B. pp. 2297-2302.
@article{3c3b4369696d42778ade022461516c02,
title = "The inhibitory effect of matrix metalloproteinase inhibitor ONO-4817 on lymph node metastasis in tongue carcinoma",
abstract = "Background: ONO-4817 is a novel matrix metalloproteinase (MMP) inhibitor which has a broad inhibitory spectrum for MMPs. We investigated the inhibitory effect of ONO-4817 on cervical lymph node metastasis of tongue carcinoma. Materials and Methods: HSC-3-M3, a cell line derived from human tongue carcinoma with high metastatic potential for lymph node, was used. The direct cytotoxicity of ONO-4817 was assessed by MTT assay and the gelatinolytic activity by gelatin zymography and film in situ zymography (FIZ). The inhibitory effect on lymph node metastasis was examined by orthotopic implantation model with nude mice. Results: ONO-4817 had no direct cyototoxicity on HSC-3-M3 cells. Gelatin zymography and FIZ demonstrated a suppression of MMP-9 activation and a marked inhibition of gelatinolysis. Additionally, a suppression of cervical lymph node metastasis was shown by therapeutic experiment. Conclusion: The MMP inhibitor, ONO-4817, is a candidate for adjunctive therapy of cervical lymph node metastasis in tongue carcinoma.",
keywords = "Head and neck squamous cell carcinoma, Lymph node metastasis, Matrix metalloproteinase inhibitor, ONO-4817, Orthotopic implantation model",
author = "Taku Yamashita and Masato Fujii and Toshiki Tomita and Ryuichiro Ishiguro and Masatsugu Tashiro and Yutaka Tokumaru and Yorihisa Imanishi and Minoru Kanke and Kaoru Ogawa and Kaori Kameyama and Yoshihide Otani",
year = "2003",
month = "5",
language = "English",
volume = "23",
pages = "2297--2302",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "3 B",

}

TY - JOUR

T1 - The inhibitory effect of matrix metalloproteinase inhibitor ONO-4817 on lymph node metastasis in tongue carcinoma

AU - Yamashita, Taku

AU - Fujii, Masato

AU - Tomita, Toshiki

AU - Ishiguro, Ryuichiro

AU - Tashiro, Masatsugu

AU - Tokumaru, Yutaka

AU - Imanishi, Yorihisa

AU - Kanke, Minoru

AU - Ogawa, Kaoru

AU - Kameyama, Kaori

AU - Otani, Yoshihide

PY - 2003/5

Y1 - 2003/5

N2 - Background: ONO-4817 is a novel matrix metalloproteinase (MMP) inhibitor which has a broad inhibitory spectrum for MMPs. We investigated the inhibitory effect of ONO-4817 on cervical lymph node metastasis of tongue carcinoma. Materials and Methods: HSC-3-M3, a cell line derived from human tongue carcinoma with high metastatic potential for lymph node, was used. The direct cytotoxicity of ONO-4817 was assessed by MTT assay and the gelatinolytic activity by gelatin zymography and film in situ zymography (FIZ). The inhibitory effect on lymph node metastasis was examined by orthotopic implantation model with nude mice. Results: ONO-4817 had no direct cyototoxicity on HSC-3-M3 cells. Gelatin zymography and FIZ demonstrated a suppression of MMP-9 activation and a marked inhibition of gelatinolysis. Additionally, a suppression of cervical lymph node metastasis was shown by therapeutic experiment. Conclusion: The MMP inhibitor, ONO-4817, is a candidate for adjunctive therapy of cervical lymph node metastasis in tongue carcinoma.

AB - Background: ONO-4817 is a novel matrix metalloproteinase (MMP) inhibitor which has a broad inhibitory spectrum for MMPs. We investigated the inhibitory effect of ONO-4817 on cervical lymph node metastasis of tongue carcinoma. Materials and Methods: HSC-3-M3, a cell line derived from human tongue carcinoma with high metastatic potential for lymph node, was used. The direct cytotoxicity of ONO-4817 was assessed by MTT assay and the gelatinolytic activity by gelatin zymography and film in situ zymography (FIZ). The inhibitory effect on lymph node metastasis was examined by orthotopic implantation model with nude mice. Results: ONO-4817 had no direct cyototoxicity on HSC-3-M3 cells. Gelatin zymography and FIZ demonstrated a suppression of MMP-9 activation and a marked inhibition of gelatinolysis. Additionally, a suppression of cervical lymph node metastasis was shown by therapeutic experiment. Conclusion: The MMP inhibitor, ONO-4817, is a candidate for adjunctive therapy of cervical lymph node metastasis in tongue carcinoma.

KW - Head and neck squamous cell carcinoma

KW - Lymph node metastasis

KW - Matrix metalloproteinase inhibitor

KW - ONO-4817

KW - Orthotopic implantation model

UR - http://www.scopus.com/inward/record.url?scp=0042306604&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0042306604&partnerID=8YFLogxK

M3 - Article

C2 - 12894506

AN - SCOPUS:0042306604

VL - 23

SP - 2297

EP - 2302

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 3 B

ER -